QPPV.COM KNOWLEDGE ASSESSMENT

Knowledge Assessment: GVP Module VI — Other Organised Data Collection Systems and Solicited Sources

Test your understanding of the concepts covered by GVP Module VI: Other Organised Data Collection Systems and Solicited Sources.

Question 1 of 10Pass mark: 80%

Question 1 of 10 Which feature most clearly indicates that a digital platform is operating as an organised data-collection system for safety information?

It is accessible through the internet It contains a structured questionnaire designed to ask about adverse effects It has a large number of registered users It allows users to change their passwords online

Question 2 of 10 What additional assessment is specifically important for solicited ICSRs classified as reports from study?

A causality assessment A decision to exclude all medically serious events A determination that the patient must be enrolled in a registry A conversion of the case into a population-level signal

Question 3 of 10 A registry analysis identifies a higher incidence of hepatic events in treated patients, but no individual narratives are available. What is the most appropriate handling?

Automatically convert the analysis into one ICSR for the registry Use the finding as appropriate for signal management, aggregate evaluation or risk management Discard the finding because it lacks individual narratives Create one ICSR for every patient presumed to have had the event

Question 4 of 10 Which statement best describes the meaning of 'solicited' in this context?

The event is necessarily an adverse reaction The information was generated through active collection within an organised system The information is necessarily medically serious The report is automatically valid as an ICSR

Question 5 of 10 An MAH analyses an existing electronic health-record database and finds an increased incidence of myocardial infarction among exposed patients. What is the most appropriate immediate interpretation?

An ICSR must be created for every coded myocardial infarction The result is automatically excluded from pharmacovigilance because no patients were contacted It may be important study-level safety evidence, but individual cases should not be manufactured automatically The result must be classified as a spontaneous report

Question 6 of 10 What is the key distinction between primary-data and secondary-use non-interventional studies?

Primary-data studies are always interventional, whereas secondary-use studies are always spontaneous Primary-data studies actively collect new information, whereas secondary-use studies analyse existing data originally collected for another purpose Secondary-use studies cannot generate safety evidence The distinction is based solely on whether the study is commercially sponsored

Question 7 of 10 Which control is particularly important when the same patient may appear in a registry, study database and spontaneous-report system?

Deleting all records that have similar clinical terms Duplicate assessment and reconciliation across data streams Processing each record independently without comparison Assigning a new patient identity to every database occurrence

Question 8 of 10 Why is the commercial label of a programme insufficient for pharmacovigilance classification?

Commercial labels are prohibited in all PV documentation Programmes with the same label can use different purposes, designs and collection methods Only the vendor may classify a programme The label determines classification only after the first ICSR is received

Question 9 of 10 Which sequence most accurately reflects the article's recommended reasoning process?

Create an ICSR, classify the source, then determine whether the information was solicited Determine how information was generated, identify the source, assess ICSR validity, then determine the reporting pathway Determine seriousness, submit the case, then review the programme design Classify the commercial programme name, assign causality and ignore the data flow

Question 10 of 10 An unrelated public website contains an unsolicited patient comment describing a suspected adverse reaction. What principle from the article is most relevant?

All online information is automatically an ODCS report The information should be treated as a report from study because it was found electronically The method and context of generation must be assessed; online location alone does not establish an ODCS Online comments can never be used for pharmacovigilance

QPPV.com

Knowledge Assessment: GVP Module VI — Other Organised Data Collection Systems and Solicited Sources

Cookie Settings